Furthermore, PGD2 is assumed to be involved in hemodynamic symptoms of systemic mast cell diseases and in other symptoms such as increased mucus secretion, bronchoconstriction, and pain [2,25,35,36]. Here, PTGDS is linked to maculopapular cutaneous mastocytosis.